By RTT News, May 06, 2013, 10:31:00 AM EDT

(RTTNews.com) - NewLink Genetics Corp. ( NLNK ) reported that its first-quarter of 2013 net loss widened to $7.9 million or $0.33 per share from $4.8 million or $0.23 per share in the first quarter of 2012.

Total grant revenues for the first quarter 2013 were $302,000 compared with $471,000 for the first quarter 2012.

Research and development expense for the first quarter 2013 was $6.3 million compared with $3.8 million for the first quarter 2012. The $2.5 million increase was primarily due to increased manufacturing and clinical trial expense from the same period in 2012.

General and administrative expense for the first quarter 2013 was $2.0 million compared with $1.5 million for the first quarter 2012. This increase was primarily due to increases in personnel related expenses.

The company said it expects to end 2013 with about $40 million in cash, cash equivalents and marketable securities.

Analysts polled by Thomson Reuters expected the company to report a loss of $0.28 per share on revenues of $0.4 million for the quarter. Analysts' estimates typically exclude special items.

For comments and feedback: contact editorial@rttnews.com

http://www.rttnews.com

Follow this link:
NewLink Genetics Q1 Loss Widens - Quick Facts

Comments are closed.